US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

QuadMix Standard 002

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0104-2023
Class II · Moderate risk Terminated

QuadMix Plus

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0103-2023
Class II · Moderate risk Terminated

Mitomycin Injection Solution

Reason Lack of Assurance of Sterility

Northern VA Compounders PLLC D-0102-2023
Class II · Moderate risk Terminated

Rasagiline Mesylate Tablets 1 mg

Reason Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.

Ascend Laboratories, LLC NDC 67877-260-30 D-0159-2023
Class II · Moderate risk Terminated

BuPROPion Hydrochloride Tablets

Reason Failed Impurities/Degradation Specifications

Amerisource Health Services LLC D-0328-2023
Class II · Moderate risk Terminated

Vitamin K

Reason Lack of sterility assurance

Sentara Infusion Services D-0324-2023
Class II · Moderate risk Terminated

Vancomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0323-2023
Class II · Moderate risk Terminated

Vancomycin

Reason Lack of sterility assurance

Sentara Infusion Services D-0322-2023
Class II · Moderate risk Terminated

TPN 107gm/AA

Reason Lack of sterility assurance

Sentara Infusion Services D-0319-2023
Class II · Moderate risk Terminated

Tobramycin 660mg in Ns 66ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0317-2023
Class II · Moderate risk Terminated

Sodium Chloride 0.9 %

Reason Lack of sterility assurance

Sentara Infusion Services D-0316-2023
Class II · Moderate risk Terminated

Piperacillin / Tazobactam

Reason Lack of sterility assurance

Sentara Infusion Services D-0315-2023
Class II · Moderate risk Terminated

Penicillin

Reason Lack of sterility assurance

Sentara Infusion Services D-0314-2023
Class II · Moderate risk Terminated

Pantoprazole 30mg in Ns 7.5ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0313-2023
Class II · Moderate risk Terminated

Ondansetron 8mg in Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0312-2023
Class II · Moderate risk Terminated

Nalbuphine

Reason Lack of sterility assurance

Sentara Infusion Services D-0311-2023
Class II · Moderate risk Terminated

Nafcillin 24gm in Ns 1200ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0310-2023
Class II · Moderate risk Terminated

Mycamine 100mg in Ns 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0309-2023
Class II · Moderate risk Terminated

MORPHINE Sulfate

Reason Lack of sterility assurance

Sentara Infusion Services D-0308-2023
Class II · Moderate risk Terminated

Milrinone

Reason Lack of sterility assurance

Sentara Infusion Services D-0307-2023
Class II · Moderate risk Terminated

Metronidazole 500mg 100ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0306-2023